Jeeva News

Read the latest news and explore the latest media coverage about Jeeva

November 1, 2022

Evolution of ePROM: Advancements, Concerns, and the Way Forward

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for understanding the disease’s natural history, palliative treatments that focus primarily on symptom control, and quality of life. Electronic Patient-Reported Outcome Measures (ePROMs) are now allowing these patients to self-report health conditions and treatment effectiveness remotely.

Read full story

New Jeeva eClinical Research Technology Enables Global Diversity Inclusion and Multi-Center Collaboration

Clinical trials rely on volunteer populations that can be challenging to access and monitor. Inadequate diversity in clinical trials leads to unreliable results. Dr. Harsha Rajasimha, CEO & Founder of Jeeva Informatics, is leading the way to enable greater collaboration, diversity, inclusion, and access to decentralized clinical trials, particularly for underrepresented minorities.

Read full story

September 16, 2022

RARE Entrepreneur Series: Portrait by RARE Revolution Magazine

The personal experience of losing a child born with a rare disease and a brother with a chronic disease became the springboard for Dr. Harsha Rajasimha to apply his years of training to accelerate therapies for rare and common conditions. His steadfast commitment to listening to the rare disease community and learning exactly what the unmet need is, is at the heart of all his endeavors.

RARE entrepreneur series: meeting the beating hearts behind the RARE brands

Read full story

Black and white pencil drawing style photo of Dr Harsha Rajasimha, looking at the camera, wearing a suit and tie.

September 07, 2022; By Michaela Althouse

With the help of software, NoVa’s Jeeva wants to increase access to clinical trials

The Manassas, Virginia SaaS company is making it easier for remote patients to connect with clinical trial data. “Clinical trials, which are essentially at no cost to patients as their sponsor pays for the cost of the clinical trial, are, by definition, better than the standard of care,” Rajasimha told “Instead of relying on the insulin injections once a day or twice a day, you can actually find something better than that option.”


August 31, 2022

VIPC’s Virginia Venture Partners Invests in Jeeva to Help Increase Patient Diversity in Clinical Trials

The company’s Modular B2B cloud-based software accelerates the decentralization of clinical trials. Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in Manassas, Va.-based Jeeva. Jeeva provides a scalable eClinical Software as a Service (SaaS) platform that helps sponsors and contract research organizations (CROs) accelerate flexible clinical operations while minimizing the burden on site staff and patients. Jeeva will use this investment towards the commercialization of the SaaS platform to accelerate therapy development for therapeutic areas such as rare diseases, immunology, and oncology in the U.S. and in emerging markets such as Latin America and India, where the company has recently established strategic partnerships.

No alternative text description for this image

July 29, 2022

Eye on the Community – The importance of ePROMs to supplement clinical assessments

Electronic Patient-Reported Outcome Measures (ePROMs) offer numerous advantages over traditional approaches to clinical trials and practice, including better patient acceptance and data quality, faster completion times

July 12, 2022

Innovation in Use of Electronic Patient Reported Outcomes Is Closing The Digital Divide

Near-universal smartphone access and a technology platform approach have accelerated the use of patient-reported outcome measures in patient care and clinical research. Digital health technologies, says Dr. Harsha Rajasimha of Jeeva Informatics, present unprecedented opportunities to effectively engage and collect ePROMs remotely from diverse patient populations.

June 23, 2022

Needed: a clearer explanation of why diversity in clinical trials is important

Increasing the diversity of clinical trial participants is all the rage these days. The numbers tell the story: According to Food and Drug Administration data, in 2020 75% of trial participants were white, 11% were Hispanic, 8% were Black, and 6% were Asian. Given those numbers, regulators and sponsors are trying to broaden the recruitment of people from different racial and ethnic groups.

May 27, 2022

Neonatology Today: How Jeeva informatics' eClinical platform is transforming pediatric rare disease research

An interview between  @Jeevatrials, Founder & CEO, Ph.D.  @Harsharajasimha & Dr. Hillyer, News Anchor & Editor at Neonatology Today published in May 2022 edition. Dr. Rajasimha explained the challenges he faced & solutions.

May 23, 2022

Digital Transformation in the Life Sciences Accelerates, Set to Reshape Industry Across Next Decade

“Information technology, underpinned by advancements in Cloud computing, is no longer the understudy to the scientific, R&D lead.  Biotech, pharma, healthcare and medtech organizations need to understand that building a fully integrated, enterprise level digital ecosystem is no longer a buzzword or passing trend. ”

May 16, 2022

Pediatric Rare Disease Clinical Trials - Challenges and Solutions

Both sides need options. Clinical trial participants need to be able to get information from the comfort and safety of their own homes. Trial sponsors need to make the field of participants as diverse as possible, and at the same time, they need to make sure they’re getting informed consent. Digital technology—particularly Bring Your Own Device (BYOD)—is the way to satisfy all stakeholder requirements.

May 16, 2022

People and Business News — 5/22

Greater Gift announces new board members, Clare Grace, Sharon Hanlon, and Harsha Rajasimha, CEO and Founder of Jeeva Informatics Solutions Inc.

Applied Clinical Trials Online

May 2, 2022

During National Small Business Week, Kaine Highlights Viriginia Small Business Success Storoes

“ Today, U.S. Senator Tim Kaine is highlighting small business success stories from across the Commonwealth in honor of National Small Business Week (May 1-7), a week dedicated to supporting small businesses. As the Senate debates additional legislation to support small businesses, Kaine will continue to make the case about why more support for Virginia small businesses is necessary.”

April 5, 2022; By Harsha Rajasimha, MS, Ph.D.

How advanced platforms for informed consent can reinforce trust in clinical trials, improve compliance

Informed consent isn’t as simple as getting verbal or written consent from a participant one time. Rather, it is the start of an ongoing relationship based on communication. Conducting a successful clinical trial depends on well-designed patient recruitment procedures and retaining the research participants until the completion of the study. The participants must receive information regarding the study and voluntarily agree to participate. This process is known as informed consent, which isn’t as simple as getting verbal or written consent from a participant.

patient engagement

April 5, 2022

Technology Being Challenged by Upsurge in Decentralized Clinical Trials

“As new non-COVID-related clinical trials proliferate, the need for effective global decentralized CT management is becoming even more apparent. What is needed, says Dr. Harsha Rajasimha of Jeeva Informatics, is to expand the capabilities of validated and human-centric digital technology.”

Tysons Corner, VA: March 23, 2022

Mindshare Announces 2022 Cohort And Return to In-person Programming

Fifty-three companies were selected to participate in the invitation-only program for CEOs of innovative, fast-growing companies. ‘We are delighted to welcome this fantastic new cohort into our powerful network of more than 1,100 CEOs – and do it in person,” said Steve Balistreri, Treasurer of the Mindshare Organizing Board. “The volume of nominations and the quality of this class is evidence that entrepreneurs in the region doubled down on innovation during the past two years and are building companies that are as diverse as the region they hail from.

February 25, 2022; by Matt Phillion

Decentralizing Clinical Trials Through Disruption

“Continuity and integrity became a challenge during the last couple of years, and the overall challenge remains the same: recruitment and keeping patients for the duration of the trial so we have complete and accurate evidence about its safety and efficacy.”

February 22, 2022; by Steven Surdez of Biobuzz

Addressing Massive Health Inequities on Rare Disease Day

“Every country needs a national organization advocating for patients with rare disorders. We saw enormous progress in the US in the last 38 years after Orphan Drugs regulations were adopted. IndoUSrare is connecting resources and expertise across international borders by building the much-needed collaborative bridges between silos,” says Dr. Marshall Summar, Director of Clinical Research at the Rare Disease Institute of the Children’s National Medical Center, and Chairman of the National Organization for Rare Disorders (NORD).

February 22, 2022

Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development

February is Rare Disease Month—an important time when the rare disease community comes together to raise awareness and advocate as one for the approximately 350 million people impacted by rare diseases globally.

February 14, 2022

Management of Pediatric Clinical Trials Calls for Urgent Technological Innovation

As the number of pediatric clinical trials show signs of improvement, how to best sustain and scale them comes into play. Dr. Harsha Rajasimha of Jeeva Informatics addresses the challenges in making radical improvements in pediatric CT operations.

January 14, 2022

Jeeva Connects Remote Patients to Clinical Trials

Jeeva Informatics Solutions, Inc. won an IGNITE program grant, a competitive non-dilutive grant offered by Prince William County Department of Economic Development with a $25K cash grant for early-stage companies and $50K for companies with funding.

January 11, 2022

Decentralized Clinical Trials Raise Concerns About Informed Consent

The growing use of decentralized clinical trials has raised serious concerns regarding the verification of patient comprehension and proper informed consent. The solution, says Dr. Harsha Rajasimha of Jeeva Informatics, is to leverage the full potential of digital technology.

December 01, 2021

IRBs Scrutinizing Remote Consent, Screening, and Participation in Study Protocols

“One is communication. Research staff & patients need to be able to communicate via video, audio, text, email, in multiple ways from wherever you are. The second part is using technology to educate patients before, during, and after they participate in a clinical trial.  It’s a divine contract that happens between the doctor and the patient that needs to occur and if that must happen remotely, as it has during the pandemic in many trials for the very first time before that 99 percent of all informed consents were in person.”

December 01, 2021

Clinical Research Processes Struggle to Adapt Amidst Pandemic

Some bright spots are relieving this dark picture, notes Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics. "One bright spot," he says, "has been the speed at which vaccines against COVID have been developed. The pandemic has intensified worldwide research collaboration and a reprioritization and rethinking of the process of how healthcare is delivered or received."

November 24, 2021

Utilizing Technology to Increase Diversity, Recruitment, and Retention for Important Life-Saving Clinical Trials

When implemented efficiently, decentralization can mean real-time data capture rather than monthly or quarterly verified data by traveling clinical research associates in-person. Choosing a bring your own device (BYOD) solution can further improve diversity and access from patients located anywhere with access to a browser-enabled mobile device and Internet access. A cloud-based Software as a Service (SaaS) solution can save significant time and costs of IT infrastructure and hardware. 

November 23, 2021

Human-Centric eClinical Platforms Can Eliminate Inefficiencies Rooted in Traditional Clinical Trials

"Serious inefficiencies are hampering clinical trials of new drugs and treatments, prolonging the suffering of millions. Today’s platform technologies, says Dr. Harsha K Rajasimha of Jeeva Informatics Solutions Inc., enable more flexible trials that are faster, more efficient, and more cost-effective than traditional approaches."

November 05, 2021

Ricardo Hazell of interviews our CEO Dr. Harsha Rajasimha on the Dire Need to Diversify Clinical Trials

Ricardo Hazell of sat down with our CEO Dr. Harsha Rajasimha to discuss his perspectives on the Dire Need to Diversify Clinical Trials. “There are clinical research projects or clinical trials which can help patients living with chronic or rare diseases anywhere in the world. But 80 percent of all clinical trial participants continue to be Caucasian, most of them male and middle-aged from an affluent background.” How can digital health and SaaS technology help address this challenge?

November 02, 2021

Education, Outreach Keys to Overcoming Distrust of Clinical Trials

Michael Causey, Editor-in-Chief, Association of Clinical Research Professionals, interviews Dr. Harsha Rajasimha, CEO of Jeeva Informatics. The clinical trial industry must proactively address a record of “historical errors and misbehavior” in its treatment of minority populations if it wants to rebuild trust and increase patient involvement, says Dr. Rajasimha.

Read Full Story


October 27, 2021

Five Critical Mistakes for Disruptive Innovators to Avoid

Disruptors are defined by several characteristics. They see beyond the existing status quo and challenge it by visualizing improvement and the outcome of that solution. Innovators do not provoke anger for its own sake, but they are not afraid to upset the competition or even potential allies. They are pioneering that solution not only to help themselves but also fix an issue that has long been plaguing their industry. Here are five mistakes innovators make which are serious enough to doom their idea.


Global Disruption: Decentralizing Clinical Trials for Diversity, Faster  Results

October 19, 2021

Global Disruption: Decentralizing Clinical Trials for Diversity, Faster Results

According to data from the FDA, African Americans are only 5% of individuals included in clinical trials, despite being more than 13% of the total U.S. population. There are currently no regulatory demands on patient diversity. This leaves all minorities underrepresented in clinical trials—from women to members of the LGBTQ+ community, to people living in rural or hard-to-reach geographies.


October 13, 2021

Clinical Trials Need More Diversity—This Tech Company is Trying to Change That

Studies have found that when people with diverse backgrounds are not adequately represented, treatments shown to be effective in trials may not be effective for all populations. This is why focusing on diversity in clinical trials is critical from this point forward.


October 12, 2021

Distrust, Fear Hamper COVID Vaccinations, Clinical Trial Diversity

The medical research community needs to plan and work toward earning the trust of diverse patients in both in-person and online settings. It cannot be assumed or taken for granted. To help overcome the lingering effects of these long-ago but well-remembered occurrences, says Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics Solutions Inc., it is necessary to address patients’ fears with real facts and real data. Prospective clinical trial participants need to understand as clearly as possible what they are consenting to, what the risks might be, and how the potential results will benefit mankind.

October 11, 2021

Healthcare Innovators to Change How Industry Communicates Telehealth

Companies that organize and conduct clinical drug trials are challenged to find and retain participants. Current statistics show that 85% of all clinical trials are delayed during patient recruitment, and 30% are terminated early due to failure to enlist enough patients. Even the small proportion of trials that manage enroll the required number experience an average 30% dropout rate. However, there are companies bringing fully scalable modular software-as-a-service platform to facilitate patient enrollment, engagement, and evidence generation in clinical trials on any browser-enabled mobile device, effectively bringing much of the trial processes to the participant.

September 20, 2021

Patient-Centric Approach to Clinical Trials Improves Outcomes for All Stakeholders

According to researchers at the MIT Sloan School of Management, the probability of FDA approval of an industry-sponsored drug entering Phase One of the clinical trial process is 13.8%. A major factor in a trial’s success or failure, notes Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics Solutions Inc., is the trial sponsor’s ability to recruit and retain patients.


September 10, 2021

Patients Deserve Remote Clinical Trial Options

“It’s not reasonable, ethical, or fair to expect patients to go to a physical site when it’s not necessary” for the conduct of a clinical trial, says Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics Solutions Inc.


August 31, 2021

Decentralized Clinical Trials Boost Enrollment, Increase Patient Diversity

As medical centers were forced to focus on COVID-related care, and optional travel was curtailed by the need for physical distancing, patients’ access to clinical trial sites was reduced by some 80%. In response, notes Dr. Harsha Rajasimha, founder and CEO of Jeeva Informatics, sponsors have moved rapidly to shift as much clinical trial activity as possible from centralized locations to the patients’ homes or nearby facilities such as pharmacies—with positive results. “Decentralization,” says Dr. Rajasimha, “has proven to be highly beneficial to sponsors and patients alike, and to significantly improve patient diversity, recruitment, and retention.”



August 25, 2021

Jeeva Joins the Amazon Web Services Partner Network (APN)

Jeeva™ eClinical Cloud platform achieved the coveted Amazon Web Services (AWS) Foundational Technical Review (FTR) and Well-Architected Framework Review (WAFR) approvals. Jeeva partnered with nOps team and continuous monitoring platform to achieve this milestone. Jeeva is excited to join the Amazon partners network (APN) to pursue co-marketing and co-selling opportunities with the global AWS network.



August 22, 2021

Jeeva was named a digital innovation finalist for advancing pediatric rare disease research in the Bear Pack contest

Jeeva is proud to announce the selection among the top 4 finalists in the Bear Pack Contest conducted by the Children's National  Medical Center and Cerner Corporation. The selection was based on voting by numerous leaders from children's hospitals across the United States. This is a great validation of Jeeva's innovation, commitment, and flexible usability of software platforms to accelerate clinical research including the much neglected rare pediatric disorders.



August 15, 2021

Customer Case Study Announcement

A large US research University has signed up with Jeeva to run a 5-year longitudinal cohort study with 2500 participants on the Jeeva software. The academic research team will be transitioning over to Jeeva eClinical cloud a as single integrated platform and will retire the 3 different tools they were previously using. Their evaluation and pilot ran for the last several months.



August 01, 2021

Jeeva Wins the IGNITE Grant by Prince William County in Virginia

Jeeva is pleased to announce its selection as a winner of the competitive Prince William County IGNITE grant in Virginia. Prince William County’s IGNITE grant offers cash to selected high-growth companies and tech catalyst organizations. The $50,000 non-dilutive grant help Jeeva further commercialize the Jeeva eClinical Cloud in the thriving Bioscience park in PWC, commonwealth of Virginia, and beyond.



August 17, 2021

Removing Logistical Burdens, Maximizing Technological Solutions Could Improve Diversity in Clinical Trials

With the ongoing COVID-19 pandemic, the importance of rigorous clinical trials has been at the center of discussions regarding the development and validity of COVID-19 vaccines. However, another issue accompanying these discussions has been affecting the health care landscape for many years: the lack of diversity among the volunteers who participate in clinical trials


August 16, 2021

How Jeeva’s Technology Can Make An Important Impact In Our Overall Wellness

Our founder and CEO Harsha K. Rajasimha sat down with Authority Magazine's Dave Philistin for an in-depth interview about his entrepreneurial journey and mission to improve health outcomes through eClinical technology.


July 21, 2021

New Technology to Help Increase Patient Diversity in Clinical Trials

Patient test groups for new drugs and treatments, notes Dr. Harsha Rajasimha of Jeeva Informatics, tend to be non-diverse. However, recently developed digital health technologies can help broaden participation while reducing the logistical burden on both patients and study teams.

Read Full Story


July 16, 2021

Our advisory board member Dr. Kamala Maddali was featured in PharmaVoice

Cancer Genetics is a global company whose state-of-the-art diagnostic technologies help determine what will work best for each individual cancer patient and light a path for biophamaceurtical companies working with immunotherapies.


July 16, 2021

Jeeva was positioned in the Everest Group's inaugural #PEAKmatrix on Decentralized Clinical Trial Products for 2021

Decentralized Clinical Trials (DCTs), in which clinical trial data is collected through sensors or remote monitoring devices carried by a patient without the need to visit a site, can deliver many benefits to pharmaceutical companies, including cost savings, better patient recruitment and retention, and improved data quality.


July 13, 2021

Virginia awards grants to Tysons tech businesses for commercial research projects

Tysons Corner, VA: Two technology companies in Tysons have each received $100,000 grants as part of a new state initiative intended to support projects that turn research into commercial products or services. Gov. Ralph Northam announced yesterday (Monday) that Virginia will award $3.4 million in grants to 34 small, technology-focused businesses for the inaugural round of the Commonwealth Commercialization Fund (CCF), which launched in 2020 to help advance promising technology through the development process.


July 12, 2021

Governor Northam Announces $3.4 Million to Advance Research Commercialization in Key Technology Sectors

RICHMOND—Governor Ralph Northam today announced that 34 small technology-focused businesses in Virginia will receive a total of $3.4 million in Commonwealth Commercialization Fund (CCF) grants to commercialize research in an array of sectors, including agricultural and environmental technologies, autonomous systems, clean energy, cybersecurity, data analytics, life sciences, and space and satellites. These awards mark the inaugural funding round for CCF, which was developed through the Virginia Innovation Partnership Authority (VIPA).


June 14, 2021

Kennesaw State University completes a pilot study on the Jeeva eClinical Cloud Platform 

Jeeva announced the completion of a collaborative project with Kennesaw State University comparing the usability of Jeeva eClinical cloud with the REDCap software that has been in use for 5000 academic institutions worldwide. The results are pending peer-review for a journal publication anticipated in Fall 2021.



Patient Recruitment is the Elephant Slowing the Speed of Clinical Trials

Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use to evaluate and review evidence of safety and efficacy of investigational medicines in humans.

With the cost of discovery and development of one novel therapy exceeding $2.5 billion over a duration of 10-15 years, according to a 2018 PhRMA report, initiating, conducting, and successfully completing a clinical trial of any kind is one of the most complex endeavors.

Download the free white paper


World Virtual Clinical Trial Service Providers Market 2020-2025, by Type of Therapeutic Area, End-Users, Phase of Development and Key Geographies

Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trial Service Providers Market by Type of Therapeutic Area, End-Users, Phase of Development (Phase I, Phase II, Phase III and Phase IV), and Key Geographies: Industry Trends and Global Forecasts, 2020-2050" report has been added to's offering.

Source: Research and MarketsRead full story


January 28, 2021

Jeeva Informatics Hosts Rare Disease Panel on Decentralized, Patient-Focused Clinical Trials

In recognition of Rare Disease Day 2021, Jeeva Informatics (Jeeva) brought together a panel of experts to discuss the importance of transforming the clinical trial process for rare diseases. The panel included Annie Kennedy, Chief of Policy and Advocacy, EveryLife Foundation for Rare Diseases; Thomas Lester, Former Executive Director, Audentes Therapeutics; Scott Schliebner, Senior Vice President, Scientific Affairs & Therapeutic Expertise, PRA Health Sciences; and Dr. Eric Sid, Program Director, National Center for Advancing Translational Science, Office of Rare Disease Research, (NCATS)/NIH.

Read full story


January 08, 2021

Jeeva Founder and CEO to Present to Investors at the 39th Annual JP Morgan Healthcare Conference January 11-14, 2021

Jeeva AI-driven eClinical cloud accelerates #clinicalresearch at scale with remote touchless patient recruitment and patient retention.

Schedule an appointment with on the BIO one on one partnering portal or here:

We look forward to kicking off the year with #JPM2021.

Read full story


December 21, 2020

Holiday virtual networking and celebration with friends of Jeeva hosted by Harsha Rajasimha

Register here

Read full story


December 16, 2020

Jeeva's perspective article published on the Patient Worthy portal

Avoid These 5 Real-World Data Pitfalls When Planning your Patient Registry, Natural History, or Other Clinical Study for a Rare Disease

1.      Don’t toggle between multiple software to manage the study.

2.      Don’t expect your clinical team to manually configure & execute the study.

3.      Don’t confuse informed consent with collecting signatures (electronic or otherwise).

4.      Don’t skip planning for travel restrictions that could halt in-person office visits.

5.      Don’t limit your study participants to a specific mobile device manufacturer.

Read full story


May 13, 2020

Jeeva to present at the KiwiTech's First Online Version of its Minority Founders Demo Day

KiwiTech, a tech startup accelerator that helps early to growth-stage startups in their product development drive traction and access capital, announced that it will host the 4th edition of its Minority Founders Demo Day on May 14, 2020, virtually for the first time.

Read more

April 08, 2020

KiwiTech and Jeeva Informatics Solutions Announce Strategic Partnership

Washington, DC: KiwiTech, LLC, an innovation platform that helps startups build viable products, drive traction, and raise capital, today announced a strategic partnership with Jeeva Informatics Solutions Inc, an AI-driven startup that builds patient-focused big data and digital health solutions for accelerating clinical research.
Source: Benzinger
Read more

March 12, 2020
Speeding Up the Search for Cures – Jeeva Informatics Solutions

By any measure, Harsha Rajasimha, PhD, was a successful man. He had published journal articles and chapters in professional textbooks; he had received patents, honors, and awards for his work. But none of these accomplishments equipped him to help his baby, who died from Edwards Syndrome, a rare congenital disease.
Source: America's SBDC
Read more

February 2020
This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials
For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, advocacy groups, regulatory bodies like the Food & Drug Administration (FDA) and other key stakeholders have to “Think Different”, as Apple famously encouraged.
Source: BioBuzz
Read more

Jan. 29, 2020

Five Biotechs Poised to Advance Their Rare Disease Programs in 2020

The Biohealth Capital Region (BHCR) is at the leading edge of the rare disease market with companies like American Gene TechnologiesREGENXBIOCerecorAsklepion Pharmaceuticals, Lediant, and others advancing their pipelines towards rare disease treatments and cures. The region’s robust rare disease sector also includes a host of companies that support rare disease research and development like Jeeva Informatics, GeneDx, Aperiomics and HemoShear among others. In short, the portfolio of rare disease companies and growing support ecosystems make the BHCR a global hub for rare disease R&D.

Source: Steve Surdez, StoryCore contribution to
Read more

Jan. 08, 2020
CIT GAP Funds Invests in Jeeva to Decentralize and Improve Clinical Trial Operations
The Center for Innovative Technology (CIT) today announced that CIT GAP Funds has invested in Herndon, Va.-based Jeeva Informatics Solutions Inc. (Jeeva), a precision medicine data science company focused on significantly accelerating clinical trial operations by taking trials to patients’ homes. Using AI and digital health technologies, Jeeva fast tracks patient recruitment, improves adherence to trial protocols, and reduces patient burden and dropout rates, solving some of the pressing challenges in bringing innovative medicines to market effectively. Jeeva plans to use the GAP Funds investment to advance customer pilot projects and use cases for further validation.
Source: Press release
Read more

Sep 11-13, 2019

Recent Advances in Systems and Network Medicine: Meeting Report from the First International Conference in Systems and Network Medicine

The First International Conference in Systems and Network Medicine gathered together 200 global thought leaders, scientists, clinicians, academicians, industry and government experts, medical and graduate students, postdoctoral scholars, and policymakers. Held at Georgetown University Conference Center in Washington D.C. on September 11–13, 2019, the event featured a day of pre-conference lectures and hands-on bioinformatics computational workshops followed by two days of deep and diverse scientific talks, panel discussions with eminent thought leaders, and scientific poster presentations. Topics ranged from Systems and Network Medicine in Clinical Practice; the role of -omics technologies in Health Care; the role of Education and Ethics in Clinical Practice, Systems Thinking, and Rare Diseases; and the role of Artificial Intelligence in Medicine. The conference served as a unique nexus for interdisciplinary discovery and dialogue and fostered the formation of new insights and possibilities for health care systems advances.
Read more

April 30, 2019

Industry Leaders Outline Five Important Elements Impacting Rare Disease Drug Development

Leaders from AstraZeneca, American Gene Technologies, REGENXBIO, GeneDX, and Jeeva Informatics Solutions recently converged on the newly redesigned 704 Quince Orchard innovation space in Gaithersburg, Maryland for a panel discussion on drug development and rare disease.
Source: BioBuzz
Read more

September 12, 2018

Summer Internship Program in Precision Medicine Creates a Win-Win for Students and Local Company

Technologies such as cloud, bigdata, nosql databases, mobile apps, wearable sensors, and healthcare data interoperability are buzz words to many, but they are technologies that are propelling the healthcare-IT field forward into new frontiers.  The possibilities these technologies bring can aide in patient engagement, data aggregation, integration and analytics for precision medicine. This is the cutting-edge space that Jeeva Informatics, a local company, operates in.  It’s also a very attractive field for students who are eager to get work experience in the emerging technologies of the future.
Source: BioBuzz

Read more